The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY — Stella

View on ClinicalTrials.gov

Recruiting

Back to Hiv trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Canada

Unity Health Toronto -St. Michael's Hospital, Toronto, Ontario

Maple Leaf Medical Clinic, Toronto, Ontario

Key details

Sponsor

University of Toronto

Collaborators

Ontario HIV Treatment Network, Maple Leaf Research

Enrollment target

~26 participants

Started

January 2025

Primary completion

November 2027

Age range

18 Years – 89 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.